🕵️ Maravai Lifesciences Holdings, Inc. ($MRVI)
SEC insider & ownership activity, last 12 months · CIK 1823239 · every row links its SEC filing
Over the last 12 months insiders sold $254K against $1.9M of open-market buying. Brust Bernd bought $1.5M in discretionary trades (Nov). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $1.9M (5 lots) · 1 seller, $254K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Brust Bernd | 3 | $1.5M | 0 | – | Nov 13, 2025 |
| Gregory T. Lucier | 2 | $369K | 0 | – | Dec 8, 2025 |
| Oreshack Kurt | 0 | – | 2 | $254K | Jun 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.9% | 13G | Oct 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Oreshack Kurt | $128K | Jun 10, 2026 | filing ↗ |
| Oreshack Kurt | $126K | Jun 9, 2026 | filing ↗ |
| Prahalad Murali | $13K | Dec 23, 2025 | filing ↗ |
| Hopfield Jessica | $188K | Dec 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 2, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jun 2, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 26, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 21, 2025 | filing ↗ |